Insider Trading & Ownership of David Pacitti

Location
Austin, TX
Summary
The estimated net worth of David Pacitti is at least $4,634,419 dollars as of 16 Apr 2026. David Pacitti is the Chief Executive Officer of AVANOS MEDICAL, INC. and owns shares of AVANOS MEDICAL, INC. (AVNS) stock worth about $4.51M. David Pacitti is the Director of Orchestra BioMed Holdings, Inc. and owns shares of Orchestra BioMed Holdings, Inc. (OBIO) stock worth about $120.5K.
Signature
/s/ John Hurley, as attorney-in-fact for David Pacitti
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow David Pacitti and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • David Pacitti has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $4,634,419.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: AVANOS MEDICAL, INC. ($4,513,905).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of David Pacitti

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AVNS AVANOS MEDICAL, INC. Chief Executive Officer $4,513,905 14 Apr 2026
OBIO Orchestra BioMed Holdings, Inc. Director $120,514 07 Aug 2025
APEN Apollo Endosurgery, Inc. Director 04 Apr 2023

Insider Transactions Reported by David Pacitti:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .